Serena Williams is under fire from fans after she revealed she lost more than 30 pounds with the help of a GLP-1 medication.

Employers and benefits advisors are facing a growing challenge: How to offer access to these high-demand, life-changing ...

Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

The 23-time Grand Slam champion says the medication is no shortcut, but a tool alongside exercise, diet and discipline ...

About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...

Serena Williams sparked a heated debate after revealing she lost 31 pounds using a GLP-1 drug. While the tennis legend ...

For individuals with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a slightly increased risk for incident diabetic retinopathy (DR) and with a ...

In a recent video spot, the 43-year-old athlete reveals that Ro helped her lose 31 pounds in eight months. “Yes, I’m on Ro.

A new study shows people on GLP-1 medicine could have lower cancer risks. San Diego is suing a growing number of residents, businesses and victims over 2024 flooding ...

A new Business Group on Health survey finds that nearly a quarter of all employer healthcare spending (24%) went to pharmacy ...

Ex-NFL QB Urges Teams to Make Trade Calls for Cowboys Star Micah Parsons Long-elusive Mexican drug lord Ismael ‘El Mayo’ Zambada pleads guilty in US Florida announces new initiative to find illegal ...

It’s a grand slam partnership for telehealth provider Ro. World renowned tennis star Serena Willams is partnering with the ...